日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With HER2 Alterations: A Phase Ia Dose-Escalation Study

HER2选择性酪氨酸激酶抑制剂Zongertinib(BI 1810631)治疗HER2改变的晚期/转移性实体瘤患者:一项Ia期剂量递增研究

Heymach, John V; Opdam, Frans; Barve, Minal; Tu, Hai-Yan; Wu, Yi-Long; Berz, David; Schröter, Lukas; Botilde, Yanick; Sadrolhefazi, Behbood; Serra, Josep; Yoh, Kiyotaka; Yamamoto, Noboru

Open-label, phase Ia study of STING agonist BI 1703880 plus ezabenlimab for patients with advanced solid tumors

一项开放标签的 Ia 期研究,评估 STING 激动剂 BI 1703880 联合 ezabenlimab 治疗晚期实体瘤患者的疗效。

Harrington, Kevin; Kitano, Shigehisa; Gambardella, Valentina; Parkes, Eileen E; Moreno, Irene; Alonso, Guzman; Doi, Toshihiko; Berz, David; Gutierrez, Martin E; Fernandez, Natalia; Schmohl, Michael; Barrueco, José; LoRusso, Patricia

Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers

Beamion BCGC-1:zongertinib治疗晚期HER2阳性乳腺癌或胃食管癌的Ib/II期试验

Hurvitz, Sara; Simonelli, Matteo; Yarza, Ramón; Berz, David; Kitano, Shigehisa; Del Conte, Gianluca; Acosta Eyzaguirre, Daniel; Doger de Speville Uribe, Bernard Gaston; Maier, Daniela; Erzen, Damijan; Aykut Yazgili, Sila; Curigliano, Giuseppe; Deng, Ting; Yan, Min; Zhang, Qingyuan; Wang, Xian; Nakayama, Izuma; Shitara, Kohei

MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy

MRTX-500 II期试验:Sitravatinib联合Nivolumab治疗接受或正在接受免疫检查点抑制剂治疗或化疗后进展的非鳞状非小细胞肺癌患者

He, Kai; Berz, David; Gadgeel, Shirish M; Iams, Wade T; Bruno, Debora S; Blakely, Collin M; Spira, Alexander I; Patel, Manish R; Waterhouse, David M; Richards, Donald A; Pham, Anthony; Jotte, Robert; Hong, David S; Garon, Edward B; Traynor, Anne; Olson, Peter; Latven, Lisa; Yan, Xiaohong; Shazer, Ronald; Leal, Ticiana A

Novel compound 1,3-bis (3,5-dichlorophenyl) urea inhibits lung cancer progression.

新型化合物 1,3-双(3,5-二氯苯基)脲可抑制肺癌进展

Singhal Sharad S, Figarola James, Singhal Jyotsana, Nagaprashantha Lokesh, Berz David, Rahbar Samuel, Awasthi Sanjay

Marrow cell genetic phenotype change induced by human lung cancer cells

人肺癌细胞诱导的骨髓细胞遗传表型改变

Del Tatto, Michael; Ng, Thomas; Aliotta, Jason M; Colvin, Gerald A; Dooner, Mark S; Berz, David; Dooner, Gerri J; Papa, Elaine F; Hixson, Douglas C; Ramratnam, Bharat; Aswad, Bassam I; Sears, Edmund H; Reagan, John; Quesenberry, Peter J

Cremophor-induced lupus erythematosus-like reaction with taxol administration: a case report and review of the literature

聚氧乙烯蓖麻油诱发的红斑狼疮样反应与紫杉醇给药:病例报告及文献综述

Pham, Anthony Q; Berz, David; Karwan, Patricia; Colvin, Gerald A

Left sided inferior vena cava duplication and venous thromboembolism: case report and review of literature

左侧下腔静脉重复畸形合并静脉血栓栓塞:病例报告及文献复习

Milani, Cannon; Constantinou, Maria; Berz, David; Butera, James N; Colvin, Gerald A

Cryopreservation of hematopoietic stem cells

造血干细胞的冷冻保存

Berz, David; McCormack, Elise M; Winer, Eric S; Colvin, Gerald A; Quesenberry, Peter J